Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yifeng Pharmacy Chain CoSHSE:603939 -1.00%90 EBITDA Margin % is 12.42% as of Mar. 2026, which is 26% below its 10-year median of 16.69. GuruFocus rates SHSE:603939 with a GF Score™ of 90/100 and a GF Value™ of ¥26.47 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 662 Healthcare Providers & Services companies, Yifeng Pharmacy Chain Co ranks better than 52.57% on this metric.
Yifeng Pharmacy Chain Co (SHSE:603939) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Yifeng Pharmacy Chain Co EBITDA Margin % Related Terms
Yifeng Pharmacy Chain Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yifeng Pharmacy Chain Co EBITDA Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Yifeng Pharmacy Chain Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yifeng Pharmacy Chain Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yifeng Pharmacy Chain Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Yifeng Pharmacy Chain Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yifeng Pharmacy Chain Co (SHSE:603939) has a EBITDA Margin % of 12.42% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Yifeng Pharmacy Chain Co and its competitors. This is 26% below median its historical median of 16.69. Over the past decade, Yifeng Pharmacy Chain Co's EBITDA Margin % has ranged from 9.21 to 17.90. According to the industry distribution chart, Yifeng Pharmacy Chain Co ranks #314 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 47.4%.
Is Yifeng Pharmacy Chain Co's EBITDA Margin % too high?
Yifeng Pharmacy Chain Co's current EBITDA Margin % of 12.42% is 26% below median its 10-year median of 16.69. Over the past 10 years, this metric has ranged from a low of 9.21 to a high of 17.90. The Healthcare Providers & Services industry median EBITDA Margin % is 10.25. Yifeng Pharmacy Chain Co's value of 12.42% is 21.2% above this industry median. Based on the distribution chart, Yifeng Pharmacy Chain Co ranks #314 out of 662 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Yifeng Pharmacy Chain Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Yifeng Pharmacy Chain Co's EBITDA Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Yifeng Pharmacy Chain Co ranks #314 out of 662 companies for EBITDA Margin %. This puts Yifeng Pharmacy Chain Co in the upper half of its industry. The industry median EBITDA Margin % is 10.25. Yifeng Pharmacy Chain Co's value of 12.42% is 21.2% above this benchmark. Historically, Yifeng Pharmacy Chain Co's own EBITDA Margin % has ranged from 9.21 to 17.90 over the past decade. While the company's 10-year median is 16.69 vs. the industry median of 10.25, Yifeng Pharmacy Chain Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.25, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yifeng Pharmacy Chain Co's current EBITDA Margin % of 12.42% is 21.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Yifeng Pharmacy Chain Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yifeng Pharmacy Chain Co's current EBITDA Margin % is 12.42%, which is 26% below median its own 10-year median of 16.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yifeng Pharmacy Chain Co stock overvalued right now?
Based on GuruFocus' analysis, Yifeng Pharmacy Chain Co (SHSE:603939) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥26.47, compared to a current price of ¥21.78 — trading 17.7% below its estimated fair value. The current EBITDA Margin % is 12.42%, which is 26% below median its 10-year median of 16.69 and 21.2% above the Healthcare Providers & Services industry median of 10.25. Yifeng Pharmacy Chain Co's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Yifeng Pharmacy Chain Co (SHSE:603939), the current EBITDA Margin % is 12.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yifeng Pharmacy Chain Co (SHSE:603939) Overvalued in 2026?
Based on GuruFocus' analysis, Yifeng Pharmacy Chain Co stock appears to be undervalued.
The current stock price of ¥21.78 is trading 17.7% below its estimated GF Value™ of ¥26.47.
GuruFocus considers Yifeng Pharmacy Chain Co to be Modestly Undervalued.
Key valuation signals for SHSE:603939:
EBITDA Margin %: 12.42% (26% below median its 10-year median of 16.69)
GF Value™: ¥26.47 vs. price of ¥21.78 (17.7% below fair value)
Industry Position: 21.2% above the Healthcare Providers & Services median (#314 of 662)
No single metric tells the full story. See the SHSE:603939 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yifeng Pharmacy Chain Co Ltd is mainly engaged in the chain retail business of medicines, health products, medical devices, and health-related daily convenience products. Its operating segments include the Retail segment and the Wholesale segment.
90GF Score
Get the complete analysis for SHSE:603939
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603939 has been successfully added to your 
